Income Statement
PELTHOS THERAPEUTICS INC.
PTHS
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Revenue
|
16.80 | - | - |
|
Cost of Revenue
|
3.99 | - | - |
|
Gross Profit
|
12.81 | - | - |
|
Operating Expenses
|
43.68 | 7.57 | 6.86 |
|
Research & Development
|
1.23 | 1.18 | 2.58 |
|
Selling, General & Administrative
|
42.45 | 4.11 | 2.74 |
|
Other Operating Expenses
|
- | - | - |
|
Operating Income
|
-30.87 | -7.57 | -6.86 |
|
Non-Operating Income
|
-18.28 | -0.38 | -0.52 |
|
Interest Income
|
- | - | - |
|
Interest Expense
|
- | 0.58 | 0.01 |
|
Other Non-Op Income / Expense
|
- | - | - |
|
Income Before Tax
|
-50.71 | - | -7.38 |
|
Income Tax Expense
|
-7.39 | - | 0.00 |
|
Non-Controlling Interest
|
- | - | - |
|
Net Income
|
-43.32 | -7.96 | -7.38 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - |
|
EBITDA
|
-30.87 | -7.57 | -6.86 |
|
Earnings Per Share (Basic)
|
-23.04 | - | 5.78 |
|
Diluted EPS
|
-23.04 | -1.43 | - |
|
Weighted Average Shares
|
1.88 | - | 1.28 |
|
Diluted Weighted Avg Shares
|
1.88 | 5.57 | - |
|
Comprehensive Income
|
-6.06 | - | - |